Holen Sie sich die Stockscreener-App
1.70
1.80%
0.03
Handel nachbörslich:
1.70
Schlusskurs vom Vortag:
$1.67
Offen:
$1.73
24-Stunden-Volumen:
468.33K
Relative Volume:
1.79
Marktkapitalisierung:
$3.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.56M
KGV:
-0.3269
EPS:
-5.2
Netto-Cashflow:
$-19.35M
1W Leistung:
-56.52%
1M Leistung:
-76.19%
6M Leistung:
-3.95%
1J Leistung:
-23.08%
1-Tages-Spanne:
$1.65
$1.81
1-Wochen-Bereich:
$1.52
$3.98
52-Wochen-Spanne:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Firmenname
Biovie Inc
Sektor
Branche
Telefon
775-888-3162
Adresse
680 W NYE LANE, CARSON CITY
Vergleichen Sie BIVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.70 | 3.32M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Eingeleitet | B. Riley Securities | Buy |
Biovie Inc Aktie (BIVI) Neueste Nachrichten
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design - GlobeNewswire
BioVie Completes $10.4 Million Public Offering to Strengthen Financial Position - AInvest
BioVie Completes $10.4 Million Public Offering - TipRanks
BioVie closes $12 million public offering of units By Investing.com - Investing.com Nigeria
BioVie Inc. Announces Closing of $12 Million Public Offering - GlobeNewswire
BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline - Stock Titan
Bloomberg to Air New to The Street Episode #683 Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - AInvest
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - ACCESS Newswire
BioVie stock dips on pricing $12M securities offering - MSN
BioVie Raises $12mln, Sees Upside to $55.00, Analysts Call it an "Outperform" Investment Opportunity - AInvest
BioVie Prices 6M Share Secondary at $2.00, Below Last Closing Price of $2.91 - AInvest
BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewswire
BioVie (BIVI.O) Crashes 42.78%: What's Behind the Sharp Intraday Move? - AInvest
Biovie stock plunges after pricing $12 million public offering By Investing.com - Investing.com Canada
Biovie stock plunges after pricing $12 million public offering - Investing.com
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results - Benzinga
BioVie's 45% Plunge: A Capital Raise Gone Wrong? - AInvest
Dow Surges 300 Points; American Axle & Manufacturing Posts Upbeat Earnings - Benzinga
BioVie Announces $12M Securities Offering - AInvest
BioVie's (BIVI) 43% Plunge: A Volatile Turn in the Biotech Arena? - AInvest
BioVie Stock Dips After Share Offering News - timothysykes.com
Why Is BioVie Stock (BIVI) Down 50% Today? - TipRanks
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed - Stock Titan
BioVie prices $12 million public offering of units at $2.00 each - Investing.com
Biovie's $12M Equity Raise: Is This a Strategic Lifeline or a Warning Signal for Small-Cap Biotechs? - AInvest
BioVie Inc. Raises $12 Million in Public Offering - AInvest
Biovie announces pricing of $12 million public offering - MarketScreener
Biovie Announces Pricing Of $12 Million Public Offering - TradingView
BioVie Inc. Announces Pricing of $12 Million Public Offering - Benzinga
What is the risk reward ratio of investing in BioVie Inc. stockHigh-velocity gains - Jammu Links News
Is it the right time to buy BioVie Inc. stockSkyrocketing profit margins - Jammu Links News
What catalysts could drive BioVie Inc. stock higher in 2025Achieve rapid returns with smart investment plans - Jammu Links News
Does BioVie Inc. stock perform well during market downturnsExplosive capital appreciation - Jammu Links News
How strong is BioVie Inc. company’s balance sheetUnprecedented profit potential - Jammu Links News
What are BioVie Inc. company’s key revenue driversInvest confidently with professional market insights - Jammu Links News
How does BioVie Inc. compare to its industry peersFree Risk Assessment Services - Jammu Links News
What institutional investors are buying BioVie Inc. stockStay ahead with advanced stock screening tools - Jammu Links News
Is BioVie Inc. stock overvalued or undervaluedMarket-beating returns - Jammu Links News
BioVie Inc. Stock Analysis and ForecastUnstoppable profit momentum - Jammu Links News
Should I hold or sell BioVie Inc. stock in 2025Free Stock Market Query - Jammu Links News
Why is BioVie Inc. stock attracting strong analyst attentionExplosive portfolio gains - Jammu Links News
When is BioVie Inc. stock expected to show significant growthUnlock expert insights for smarter investing - Jammu Links News
What makes BioVie Inc. stock price move sharplyOutstanding stock performance - Jammu Links News
What are the latest earnings results for BioVie Inc.Chart Pattern Forecasts For Consistent Profits - Jammu Links News
Why BioVie Inc. stock attracts strong analyst attentionValue Driven Trading Forecast Analysis - beatles.ru
Finanzdaten der Biovie Inc-Aktie (BIVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):